Correlation of PET-CT Studies With Serum Protein Analysis

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00547742

Enrollment

1500

Registered

2007-10-23

Start date

2005-07-31

Completion date

2009-06-30

Last updated

2010-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carcinomas (Including Squamous Cell and Adenocarcinoma)

Brief summary

To correlate serum proteomics patterns with PET/CT findings to improve cancer diagnosis, staging, prognosis, and therapy monitoring.

Interventions

PROCEDUREPET/CT Scan

PROCEDUREphlebotomy

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

1. Patients must have a PET/CT study performed at the time of blood collection. 2\. Patients must understand and voluntarily sign an Informed Consent form after the contents have been fully explained to them.

Exclusion criteria

1. Patients who are not eligible for a PET/CT study.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026